The Future of Diversity, Inclusion, & Equity in Medicine & Technology Workshop
Friday, September 20, 2019 | 9:00 AM – 12:00 PM PST
San Francisco, CA
About the Roundtable
This workshop brings together best-in-class physicians, diversity and equity professionals, technologists, entrepreneurs, healthcare executives, investors, researchers, and healthcare professionals from the Bay Area and across the U.S. to discuss the interesting intersection of equity, healthcare, and technology. The emphasis will be on compelling, cross-functional, and inter-disciplinary themes. The workshop will focus on the opportunities, challenges, and best practices of leveraging technology to make modern healthcare more equitable for all patients. Additionally, we will discuss the business case for how diversity, inclusion, and equity --in addition to being beneficial for humanity and society-- are catalytic for decreasing costs, increasing revenues, and ultimately driving higher profits at the organizational level. The event will punctuate the critical importance of diversity, inclusion, and engagement for modern organizations. This workshop is a collaborative, engaging, highly interactive exchange of ideas and information, with the hope and expectation that multiple subsequent collaborations between participants will emerge in the wake of the event.
LEARN the business case for how diversity, inclusion, and equity are catalytic for decreasing costs, increasing revenues, and ultimately driving higher profits at the organizational level
UNDERSTAND the critical importance of diversity, inclusion, and engagement for modern organizations.
DISCUSS the relationships among AI, technology, diversity, and equity
FOCUS on the interesting intersection of business, management, strategy, and technology
NETWORK with best-in-class entrepreneurs, executives, investors, policymakers, researchers, scientists, and technologists from the Bay Area and across the U.S.
Key organizations represented include: Apple, Black Girls Code, California College of Arts, eBay, Girl Stem Stars, HP, J&J, San Francisco Arts Commission, Siemens Healthineers, Stanford University, and University of California Berkeley.
Dr. James J. Gillespie, PhD, JD, MPA, is a consultant, researcher, and scholar in the application of advanced analytics, business intelligence, and big data to address challenges and opportunities for healthcare, biopharmaceutical, medical, and technology companies. His research has appeared in numerous peer-reviewed academic outlets and top industry/trade journals, and he is the lead author of the book: "Patient-Centric Analytics in Health Care: Driving Value in Clinical Settings and Psychological Practice” published by Lexington Books. With two MD physician colleagues, he is working on a new book: "AI and Machine Learning: Revolutionizing the Future of Healthcare and Medicine." Dr. Gillespie’s research has appeared in Academy of Management Review, American Behavioral Scientist, European Journal of Social Psychology, Federal Reserve Bank, Harvard Business Review, and Strategic Management Journal. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; Carnegie Mellon University Heinz School; and Rand Graduate School.
Distinguished Keynote Address
Doug Harris is the Chief Executive Officer of The Kaleidoscope Group with over 25 years of experience in the field of diversity & inclusion consulting. Prior to joining Bea Young Associates in 1993, Doug worked for several years as a consultant and trainer for Harbridge House, Inc. where he facilitated diversity & inclusion education sessions with senior executives of Fortune 500 organizations. Today, as the leader of The Kaleidoscope Group, Doug empowers organizations to achieve their diversity and inclusion goals. His knowledge and expertise guides organizations through the creation of customized strategies that address the specific diversity needs of the business. He has extensive experience working with senior executives to champion diversity and develop commitment and enthusiasm across all employee groups. His energy and passion for the work is contagious and people seldom walk away without a memorable experience. Some of Doug’s clients include: Blue Cross Blue Shield, Coca-Cola Enterprise, CNA, Gulfstream Aerospace Corporation, John G. Shedd Aquarium, Farmers Insurance, McDonald’s Corporation, Nationwide Insurance, Northwestern Memorial Hospital, Northwestern University Kellogg School of Management, Provena Health, The Federal Reserve Banks, The Wharton School, Watson Wyatt Worldwide, and several nonprofit social service/government agencies.
Distinguished Opening Remarks
Dr. Ronald L. Copeland, MD, FACS, is senior vice president of National Equity, Inclusion, and Diversity strategy and policy and chief equity, inclusion and diversity officer for Kaiser Permanente. He leads Kaiser Permanente's efforts to ensure our strategic vision for equity, inclusion, and diversity is successfully implemented to drive strategic business and mission outcomes and results in all Kaiser Permanente members achieving health and health care outcomes that are high quality, equitable, and increasingly more affordable. A board-certified general surgeon, Dr. Copeland joined Kaiser Permanente in 1988 after a six -year honorable tour of duty in the United States Air Force Medical Corps. Dr. Copeland served as president and executive medical director of the Ohio Permanente Medical Group prior to assuming his current role in 2012. He earned his bachelor’s degree from Dartmouth College and medical degree from University of Cincinnati Medical College, and completed his residency in general surgery at State University of New York Upstate Medical Center in Syracuse. He also attended the Advanced Management Program at Harvard Business School. In the fall of 2016, Dr. Copeland was appointed to the board of Kaiser Permanente’s School of Medicine (opening in 2020). He is a fellow of The American College of Surgeons; a member of the Healthcare Delivery and Disparities Research Advisory Panel; a board member of the National Organization on Disability; a committee member of the National Quality Forum Disparities Standing Committee. In January 2016, Becker’s Hospital Review recognized Dr. Copeland as one of “15 hospital and health systems chief diversity officers to know.”’
Distinguished Closing Remarks
Julius Pryor helps companies leverage Diversity & Inclusion to accelerate innovation and drive business results. He’s held executive roles at Johnson & Johnson (J&J), Coca-Cola Enterprises (CCE), Russell Athletic, Abbott Labs and Takeda Pharmaceuticals. He was Vice President of Global Diversity at both J&J and Coke. Most recently, Julius served as Head of Innovation, Diversity & Inclusion at biotech leader Genentech. Julius combines a unique vision for the future of D&I, a strong grounding in sales and management, and insights into what works across different industries and sectors. Julius saw the power of diversity to accomplish results during his 26 years of service in the U.S. Navy. He is a U.S. Navy Captain, Surface Warfare Officer and Instructor for the Navy Officer Leadership Development Program. He’s held numerous Navy leadership roles including, Unit Commanding Officer and Fleet Staff Officer. He had the honor of serving on the re-commissioning crew of the historic USS Missouri (BB-63). Julius graduated from Morehouse College and The Williston Northampton School (Easthampton, MA).
Registration & Networking
Distinguished Opening Remarks
Distinguished Keynote Address